vancomycin has been researched along with Adverse Drug Event in 65 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (4.62) | 18.2507 |
| 2000's | 2 (3.08) | 29.6817 |
| 2010's | 32 (49.23) | 24.3611 |
| 2020's | 28 (43.08) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
| Hebert, S; Tantranont, N; Truong, LD | 1 |
| Imai, S; Kadomura, S; Kashiwagi, H; Miyai, T; Sato, Y; Sugawara, M; Takekuma, Y | 1 |
| Harada, S; Matsuoka, S; Mizusaki, Y; Niwa, T; Otsubo, M; Suzuki, A; Yamada, M; Yamada, Y; Yamamoto, T; Yasue, M | 1 |
| Al Alawi, AM; Al-Maqbali, JS; Al-Riyami, I; Sabahi, NA; Shukri, ZA | 1 |
| Bastard, DP; Cura, MJ; di Prinzio, A; Mazzuoccolo, LD; Puga, C; Torre, AC | 1 |
| Chandni, V; Lakshmi Prasanna, VM; M Shaju, A; Nair, G; Panicker, N; Subeesh, V | 1 |
| Alosaimy, S; Amaya, L; Biagi, M; Chandler, E; Cubillos, A; Davis, SL; Finch, N; Hobbs, ALV; Holger, D; Jorgensen, SCJ; Kufel, WD; Kunz Coyne, AJ; Lagnf, AM; Li, D; Molina, KC; Moore, WJ; Morrisette, T; Mubarez, M; Patch, M; Polisetty, RS; Rebold, N; Rico, M; Rybak, MJ; Sakoulas, G; Simon, SP; Smith, IMK; Tran, NN; Truong, J; Venugopalan, V; Veve, MP; Witucki, P; Wrin, J; Yost, C | 1 |
| Ambreen, G; Hussain, K; Ikram, R; Khan, M; Khan, WA; Naz, F; Rathi, M; Rauf, S; Salat, MS | 1 |
| Brinton, JT; Gist, KM; Hebert, M; Holsteen, PE; Iwanowski, M; Kim, A; Leath, A; Marschner, MN; Shah, A; Soranno, DE | 1 |
| Asada, M; Azuma, M; Bando, T; Chuma, M; Goda, M; Hamano, H; Ishida, S; Ishizawa, K; Izawa-Ishizawa, Y; Izumi, Y; Kasamo, S; Kondo, M; Miyata, K; Niimura, T; Okada, N; Takechi, K; Tasaki, Y; Yagi, K; Yanagawa, H; Yoshioka, T; Zamami, Y | 1 |
| Cass, A; Davies, J; Davis, JS; Johnson, SA; Legg, A; Meagher, N; Roberts, JA; Roberts, MA; Scheetz, MH; Tong, SYC | 1 |
| Ernst, G; Kot, L; Scolari, M; Trovato, D | 1 |
| Guo, S; Wang, F; Wu, Y; Yin, W | 1 |
| Haag, H; Lau, A | 1 |
| Benefield, RJ; Certain, LK; McDonald, J; Newman, M; Tritle, B | 1 |
| Imai, S | 1 |
| Hirai, T; Ishitsuka, Y; Iwamoto, T; Kondo, Y; Sakazaki, Y; Seki, A | 1 |
| Balkrishna, A; Dev, R; Gohel, V; Kumari, A; Maity, M; Rawat, M; Sharma, S; Sinha, S; Varshney, A | 1 |
| Nunez, M; Tuerff, D | 1 |
| Costa, TXD; Leopoldino, RWD; Martins, RR; Nascimento, ARFD; Santos, METD | 1 |
| Darko, W; Fazili, T; Gilotra, T; Kufel, WD; Miller, CD; Probst, LA; Seabury, RW; Shakeraneh, P; Steele, JM; Wang, D | 1 |
| Dong, Y; Du, Q; Liu, Y; Sun, D; Wang, T; You, H; Zhang, D; Zhang, T; Zhang, Y | 1 |
| Furuya, Y; Miyazaki, A; Murakami, Y; Nakashima, M; Nakashima, MN; Sakamoto, Y; Sanematsu, E; Shinohara, Y; Ueki, T | 1 |
| Imai, S; Iseki, K; Kashiwagi, H; Kobayashi, M; Miyai, T; Sugawara, M; Takekuma, Y | 1 |
| Ang, LW; Chan, CP; Looi, WL; Lye, DC; Ooi, XY; See, YP; Yeo, SC; Young, BE | 1 |
| Huebner, J; Kreitmeyr, K; Mikolajczyk, R; Pecar, A; von Both, U | 1 |
| Baker, HP; Barbosa, VH; Boyle, MM; Luu, HH; Portney, DA | 1 |
| Hashiguchi, Y; Jono, H; Katanoda, T; Nakata, H; Oda, K; Saito, H | 1 |
| Cammarata, S; Farley, B; Gardovskis, J; Lawrence, L; Ling, R; Pullman, J; Quintas, M; Sun, E | 1 |
| Azzini, AM; Baur, D; Savoldi, A; Tacconelli, E | 1 |
| Branch-Elliman, W; LaSalvia, MT; Schrank, GM; Wright, SB | 1 |
| Carreno, J; Hunter, C; Lomaestro, B; Smiraglia, T; Tobin, E | 1 |
| Pirmohamed, M | 1 |
| Hagiya, H; Hamaguchi, S; Kokado, R; Morii, D; Okuno, H; Tomono, K; Ueda, A; Yamamoto, N; Yoshida, H | 1 |
| Belknap, RW; Biffl, WL; Chaus, GW; Hak, DJ; Knepper, B; Morgan, SJ; Price, CS; Ross, E; Saveli, CC; Stahel, PF | 1 |
| An, MM; Jiang, YY; Shen, H; Xu, GT; Zhang, JD | 1 |
| Abdelhadii, A; Beumier, M; Cianferoni, S; De Backer, D; Devigili, A; Jacobs, F; Ocampos-Martinez, E; Penaccini, L; Scolletta, S; Taccone, FS; Vincent, JL | 1 |
| Devaraja, S; Girish, KS; Hemshekhar, M; Kemparaju, K; Rangappa, KS; Thushara, RM | 1 |
| Gordon, SM; Mason, P; Neuner, E; Nutter, B; O'Rourke, C; Rehm, SJ; Shrestha, NK | 1 |
| Castaing, N; Cooper, A; Dartois, N; Dukart, G; Embil, JM; Lauf, L; Maroko, R; Mitha, I; Ozsvár, Z; Regöly-Mérei, J; Sabol, MB; Yan, J | 1 |
| Chakraborty, SP; Haldar, J; Konai, MM; Mani, B; Manjunath, GB; Paramanandham, K; Prakash, RG; Ranjan, SB; Ravikumar, R; Roy, S; Yarlagadda, V | 1 |
| Nathwani, D; Tsoulas, C | 1 |
| Davies, SW; Dietch, ZC; Efird, JT; Guidry, CA; Sawyer, RG; Shah, PM; Willis, RN | 1 |
| Chen, H; Hao, JJ; Zhou, JX | 1 |
| Athans, V; Davis, SL; Kenney, RM; Wong, J | 1 |
| Dryden, M; Gonzalez, J; Iaconis, JP; Wilson, D; Zhang, Y | 1 |
| Hanes, SD; Kane, SP | 1 |
| Gruneir, A; Howard, AW; Koren, G; Parshuram, CS; Rochon, PA; Slater, MB | 1 |
| Beibei, L; Mengli, C; Nan, B; Rui, W; Xuhong, Y; Yun, C | 1 |
| McAuley, MA | 1 |
| Bourcier, T; Jehl, F; Lefèvre, S; Marcellin, L; Prévost, G; Saleh, M; Subilia, A | 1 |
| Anderson, DJ; Chen, LF | 1 |
| Allgren, RL; Sellers, S; Weiss, K | 1 |
| Campino, A; Garcia, M; Rueda, M; Santesteban, E; Valls-I-Soler, A | 1 |
| De Vriese, AS; Tacconelli, E; Vandecasteele, SJ | 1 |
| Castro, JG; Lobo, MG; Momenté, VG; Pinheiro, SM; Pranchevicius, MC | 1 |
| Grau, S; Majos, N; Rubio-Rodríguez, D; Rubio-Terrés, C | 1 |
| Hidayat, LK; Hsu, DI; Quist, R; Shriner, KA; Wong-Beringer, A | 1 |
| Iwamoto, T | 1 |
| Hafner, A; John, J; Riley, LW; Roberts, RB; Tornieporth, NG | 1 |
| Colley, CA; Lucas, LM | 1 |
| Barr, JT; Schumacher, GE | 1 |
14 review(s) available for vancomycin and Adverse Drug Event
| Article | Year |
|---|---|
A rare case of infant eosinophilia induced by oral vancomycin: a case report and literature review.
Topics: Administration, Oral; Child; Drug-Related Side Effects and Adverse Reactions; Eosinophilia; Eosinophils; Exanthema; Humans; Infant; Vancomycin | 2023 |
Correlation of Calculated Vancomycin Trough Concentrations and Exposure: A Monte Carlo Simulation.
Topics: Anti-Bacterial Agents; Area Under Curve; Drug-Related Side Effects and Adverse Reactions; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Retrospective Studies; Vancomycin | 2023 |
Patient safety outcomes for continuous infusion vancomycin as outpatient parenteral antimicrobial therapy.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Drug-Related Side Effects and Adverse Reactions; Humans; Outpatients; Patient Safety; Renal Insufficiency; Retrospective Studies; Vancomycin | 2023 |
[A Novel Approach to Analyze the Factors Affecting Adverse Drug Reactions by Combination of Electronic Medical Record Database and Machine Learning Method].
Topics: Big Data; Drug-Related Side Effects and Adverse Reactions; Electronic Health Records; Humans; Machine Learning; Vancomycin | 2023 |
Is there still a role for vancomycin in skin and soft-tissue infections?
Topics: Anti-Bacterial Agents; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Glycopeptides; Humans; Linezolid; Skin Diseases, Infectious; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2018 |
Linezolid versus vancomycin for meticillin-resistant Staphylococcus aureus infection: a meta-analysis of randomised controlled trials.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Kidney; Kidney Function Tests; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Randomized Controlled Trials as Topic; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2013 |
Therapeutic drug-induced platelet apoptosis: an overlooked issue in pharmacotoxicology.
Topics: Apoptosis; Aspirin; Blood Platelets; Cisplatin; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmacovigilance; Thrombocytopenia; Vancomycin | 2014 |
Review of meta-analyses of vancomycin compared with new treatments for Gram-positive skin and soft-tissue infections: Are we any clearer?
Topics: Anti-Bacterial Agents; Drug-Related Side Effects and Adverse Reactions; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2015 |
Continuous versus intermittent infusion of vancomycin in adult patients: A systematic review and meta-analysis.
Topics: Adult; Anti-Bacterial Agents; Drug-Related Side Effects and Adverse Reactions; Humans; Infusions, Intravenous; Kidney Diseases; Treatment Outcome; Vancomycin | 2016 |
Unexplained increases in serum vancomycin concentration in a morbidly obese patient.
Topics: Anti-Bacterial Agents; Cross Reactions; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Middle Aged; Obesity, Morbid; Pneumonia, Ventilator-Associated; Vancomycin | 2017 |
Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Drug-Related Side Effects and Adverse Reactions; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2010 |
Safety analysis of fidaxomicin in comparison with oral vancomycin for Clostridium difficile infections.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Clostridioides difficile; Clostridium Infections; Diarrhea; Dogs; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Fidaxomicin; Humans; Treatment Outcome; Vancomycin | 2012 |
The pharmacokinetics and pharmacodynamics of vancomycin in clinical practice: evidence and uncertainties.
Topics: Anti-Bacterial Agents; Drug-Related Side Effects and Adverse Reactions; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2013 |
[Pharmacokinetic and molecular biological approaches to achieve the safety and effective management of drug therapies].
Topics: Anti-Bacterial Agents; Biomarkers; Blood Glucose; Dacarbazine; Diabetes Mellitus; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Humans; Medication Errors; Nervous System Diseases; Pharmacokinetics; Prednisolone; Risk Factors; Safety Management; Vancomycin | 2007 |
6 trial(s) available for vancomycin and Adverse Drug Event
| Article | Year |
|---|---|
Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Cloxacillin; Drug-Related Side Effects and Adverse Reactions; Humans; Methicillin-Resistant Staphylococcus aureus; Prospective Studies; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2023 |
Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Aztreonam; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Fluoroquinolones; Humans; Middle Aged; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin; Young Adult | 2017 |
Prophylactic antibiotics in open fractures: a pilot randomized clinical safety study.
Topics: Adult; Anti-Bacterial Agents; Colorado; Comorbidity; Drug-Related Side Effects and Adverse Reactions; Female; Fracture Fixation, Internal; Fractures, Open; Humans; Incidence; Male; Pilot Projects; Premedication; Prosthesis-Related Infections; Risk Factors; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2013 |
Phase 3 study comparing tigecycline and ertapenem in patients with diabetic foot infections with and without osteomyelitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Diabetic Foot; Drug-Related Side Effects and Adverse Reactions; Ertapenem; Female; Humans; Male; Middle Aged; Minocycline; Nausea; Osteomyelitis; Tigecycline; Treatment Outcome; Vancomycin; Vomiting; Young Adult | 2014 |
A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Prospective Studies; Skin Diseases, Bacterial; Soft Tissue Infections; Systemic Inflammatory Response Syndrome; Treatment Outcome; Vancomycin; Young Adult | 2016 |
Efficacy and safety of fidaxomicin compared with oral vancomycin for the treatment of adults with Clostridium difficile-associated diarrhea: data from the OPT-80-003 and OPT-80-004 studies.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Female; Fidaxomicin; Humans; Male; Middle Aged; Secondary Prevention; Treatment Outcome; Vancomycin | 2012 |
45 other study(ies) available for vancomycin and Adverse Drug Event
| Article | Year |
|---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
Vancomycin Nephrotoxicity Causing Renal Transplant Acute Kidney Injury.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug-Related Side Effects and Adverse Reactions; Humans; Kidney Transplantation; Retrospective Studies; Vancomycin | 2021 |
Using Japanese big data to investigate novel factors and their high-risk combinations that affect vancomycin-induced nephrotoxicity.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Big Data; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Japan; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2022 |
Comparison of single trough-based area under the concentration-time curve versus trough concentration for the incidence of vancomycin-associated nephrotoxicity.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Area Under Curve; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Male; Retrospective Studies; Vancomycin | 2022 |
Vancomycin Therapeutic Drug Monitoring (TDM) and Its Association with Clinical Outcomes: A Retrospective Cohort.
Topics: Adult; Anti-Bacterial Agents; Cohort Studies; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Humans; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Vancomycin | 2022 |
Adverse Drug Reactions Are the Main Causes of Erythroderma in an Argentinian Teaching Hospital: A Retrospective Study of 70 Patients.
Topics: Dermatitis, Exfoliative; Drug-Related Side Effects and Adverse Reactions; Female; Hospitals, Teaching; Humans; Male; Retrospective Studies; Vancomycin | 2022 |
Drugs-associated with red man syndrome: An integrative approach using disproportionality analysis and Pharmip.
Topics: Adverse Drug Reaction Reporting Systems; Anti-Bacterial Agents; Carbonic Anhydrase II; Drug-Related Side Effects and Adverse Reactions; Humans; Molecular Docking Simulation; Nerve Tissue Proteins; Pharmacovigilance; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Syndrome; United States; United States Food and Drug Administration; Vancomycin | 2022 |
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tazobactam; Vancomycin | 2023 |
Practical approaches to improve vancomycin-related patient outcomes in pediatrics- an alternative strategy when AUC/MIC is not feasible.
Topics: Anti-Bacterial Agents; Area Under Curve; Child; Creatinine; Drug-Related Side Effects and Adverse Reactions; Humans; Renal Insufficiency; Retrospective Studies; Vancomycin | 2022 |
Nephrotoxic Exposures and Acute Kidney Injury in Noncritically Ill Children Stratified by Service.
Topics: Acute Kidney Injury; Aminoglycosides; Child; Creatinine; Drug-Related Side Effects and Adverse Reactions; Humans; Retrospective Studies; Risk Factors; Vancomycin | 2022 |
Non-recovery of vancomycin-associated nephrotoxicity is related to worsening survival outcomes: Combined retrospective analyses of two real-world databases.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug-Related Side Effects and Adverse Reactions; Humans; Retrospective Studies; Risk Factors; Vancomycin | 2022 |
[Adverse drug reactions to multiple antibiotics].
Topics: Anti-Bacterial Agents; Daptomycin; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2023 |
Drug-drug interaction signals between loop diuretics and teicoplanin during acute kidney injury evaluated using Japanese spontaneous adverse drug event reports.
Topics: Acute Kidney Injury; Diuretics; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; East Asian People; Humans; Japan; Sodium Potassium Chloride Symporter Inhibitors; Teicoplanin; Vancomycin | 2023 |
Renogrit attenuates Vancomycin-induced nephrotoxicity in human renal spheroids and in Sprague-Dawley rats by regulating kidney injury biomarkers and creatinine/urea clearance.
Topics: Animals; Biomarkers; Blood Urea Nitrogen; Creatinine; Drug-Related Side Effects and Adverse Reactions; Humans; Kidney; Lipocalin-2; Matrix Metalloproteinase 7; Rats; Rats, Sprague-Dawley; RNA, Messenger; Urea; Vancomycin | 2023 |
More Frequent Premature Antibiotic Discontinuations and Acute Kidney Injury in the Outpatient Setting With Vancomycin Compared to Daptomycin.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anti-Bacterial Agents; Daptomycin; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Odds Ratio; Retrospective Studies; Risk Factors; Vancomycin; Young Adult | 2020 |
DRUG-RELATED PROBLEMS IN CARDIAC NEONATES UNDER INTENSIVE CARE.
Topics: Anti-Bacterial Agents; Brazil; Cross-Sectional Studies; Diuretics; Drug-Related Side Effects and Adverse Reactions; Furosemide; Heart Diseases; Hospitalization; Hospitals, Teaching; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Meropenem; Pharmacists; Pharmacy Service, Hospital; Prospective Studies; Safety; Treatment Outcome; Vancomycin | 2020 |
Nephrotoxicity Risk and Clinical Effectiveness of Continuous versus Intermittent Infusion Vancomycin Among Patients in an Outpatient Parenteral Antimicrobial Therapy Program.
Topics: Acute Kidney Injury; Anti-Infective Agents; Cohort Studies; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infusions, Intravenous; Male; Middle Aged; New York; Outpatients; Propensity Score; Retrospective Studies; Risk Factors; Vancomycin | 2020 |
Therapeutic Drug Monitoring Coupled With Bayesian Forecasting Could Prevent Vancomycin-Associated Nephrotoxicity in Renal Insufficiency Patients: A Prospective Study and Pharmacoeconomic Analysis.
Topics: Aged; Anti-Bacterial Agents; Bayes Theorem; Cohort Studies; Cost-Benefit Analysis; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Economics, Pharmaceutical; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Propensity Score; Prospective Studies; Renal Insufficiency; Risk Factors; Vancomycin | 2020 |
Relationship between vancomycin-associated nephrotoxicity and the number of combined nephrotoxic agents.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Blood Urea Nitrogen; Creatinine; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Vancomycin | 2020 |
Validation of the usefulness of artificial neural networks for risk prediction of adverse drug reactions used for individual patients in clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Kidney; Logistic Models; Male; Middle Aged; Models, Statistical; Neural Networks, Computer; Prognosis; Retrospective Studies; Risk Assessment; Vancomycin; Young Adult | 2020 |
Risk Factors for Development of Acute Kidney Injury in COVID-19 Patients: A Retrospective Observational Cohort Study.
Topics: Acute Kidney Injury; Adult; Age Factors; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Comorbidity; COVID-19; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypoxia; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Vancomycin | 2021 |
Pediatric Antibiotic Stewardship: Optimization of Vancomycin Therapy Based on Individual Pharmacokinetics.
Topics: Adolescent; Anti-Bacterial Agents; Antimicrobial Stewardship; Area Under Curve; Child; Child, Preschool; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Male; Pediatrics; Prospective Studies; Tertiary Care Centers; Vancomycin | 2021 |
Drug Reaction with Eosinophilia and Systemic Syndrome in Revision Arthroplasty for a Prosthetic Knee Infection: A Case Report.
Topics: Aged; Arthroplasty; Drug-Related Side Effects and Adverse Reactions; Eosinophilia; Female; Humans; Knee Joint; Middle Aged; Vancomycin | 2021 |
Lowered Risk of Nephrotoxicity through Intervention against the Combined Use of Vancomycin and Tazobactam/Piperacillin: A Retrospective Cohort Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Kidney Diseases; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Vancomycin; Young Adult | 2021 |
A retrospective analysis of adverse events among patients receiving daptomycin versus vancomycin during outpatient parenteral antimicrobial therapy.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Communicable Diseases; Daptomycin; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infusions, Parenteral; Logistic Models; Male; Middle Aged; Outpatients; Retrospective Studies; Vancomycin | 2018 |
Comparative incidence and excess risk of acute kidney injury in hospitalised patients receiving vancomycin and piperacillin/tazobactam in combination or as monotherapy.
Topics: Academic Medical Centers; Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Creatinine; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Female; Hospital Mortality; Humans; Incidence; Length of Stay; Male; Middle Aged; New York; Piperacillin; Retrospective Studies; Risk Assessment; Tazobactam; Vancomycin; Young Adult | 2018 |
HLA- and immune-mediated adverse drug reactions: Another hit with vancomycin.
Topics: Drug Hypersensitivity; Drug Hypersensitivity Syndrome; Drug-Related Side Effects and Adverse Reactions; HLA-A Antigens; Humans; Vancomycin | 2019 |
Association of Adverse Drug Events with Broad-spectrum Antibiotic Use in Hospitalized Patients: A Single-center Study.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Vancomycin; Young Adult | 2019 |
Development of acute kidney injury during continuous infusion of vancomycin in septic patients.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Plasma; Prevalence; Sepsis; Vancomycin | 2013 |
Adverse events, healthcare interventions and healthcare utilization during home infusion therapy with daptomycin and vancomycin: a propensity score-matched cohort study.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cohort Studies; Daptomycin; Drug-Related Side Effects and Adverse Reactions; Female; Health Facilities; Home Infusion Therapy; Humans; Male; Middle Aged; Propensity Score; Retrospective Studies; Vancomycin | 2014 |
In vivo antibacterial activity and pharmacological properties of the membrane-active glycopeptide antibiotic YV11455.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; Drug-Related Side Effects and Adverse Reactions; Female; Glycopeptides; Kidney Function Tests; Liver Function Tests; Methicillin-Resistant Staphylococcus aureus; Mice; Muscles; Staphylococcal Infections; Vancomycin | 2015 |
Top Guns: The "Maverick" and "Goose" of Empiric Therapy.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Insufficiency; Retrospective Studies; Risk Assessment; Vancomycin | 2016 |
Canadian Retina Society ocular safety and therapeutics update: hemorrhagic occlusive retinal vasculitis.
Topics: Anterior Chamber; Anti-Bacterial Agents; Canada; Cataract Extraction; Drug-Related Side Effects and Adverse Reactions; Humans; Ophthalmology; Postoperative Complications; Retinal Hemorrhage; Retinal Vasculitis; Societies, Medical; Vancomycin | 2016 |
Outpatient use of ceftaroline fosamil versus vancomycin for osteoarticular infection: a matched cohort study.
Topics: Adult; Aged; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Osteoarthritis; Outpatients; Patient Readmission; Retrospective Studies; Treatment Outcome; Vancomycin | 2016 |
Identifying High-Risk Medications Associated with Acute Kidney Injury in Critically Ill Patients: A Pharmacoepidemiologic Evaluation.
Topics: Acute Kidney Injury; Adolescent; Case-Control Studies; Child; Child, Preschool; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Female; Furosemide; Gentamicins; Hospitalization; Humans; Incidence; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Male; Retrospective Studies; Risk Factors; Vancomycin | 2017 |
Allergic reaction or adverse drug effect: correctly classifying vancomycin-induced hypersensitivity reactions.
Topics: Diagnosis, Differential; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Emergency Service, Hospital; Female; Humans; Infusions, Intravenous; Male; Sensitivity and Specificity; Vancomycin; World Health Organization | 2012 |
Daptomycin versus vancomycin in a methicillin-resistant Staphylococcus aureus endophthalmitis rabbit model: bactericidal effect, safety, and ocular pharmacokinetics.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Colony Count, Microbial; Daptomycin; Disease Models, Animal; Drug-Related Side Effects and Adverse Reactions; Endophthalmitis; Eye; Female; Half-Life; Intravitreal Injections; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rabbits; Severity of Illness Index; Staphylococcal Infections; Vancomycin | 2012 |
[Intravenous drug preparation errors in a Neonatal Intensive Care Unit. A potential source of adverse events].
Topics: Drug Compounding; Drug-Related Side Effects and Adverse Reactions; Humans; Infant, Newborn; Injections, Intravenous; Intensive Care Units, Neonatal; Medication Errors; Prospective Studies; Tobramycin; Vancomycin | 2013 |
Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Analgesics, Opioid; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Brazil; Child; Child, Preschool; Dipyrone; Drug-Related Side Effects and Adverse Reactions; Female; Hospitalization; Humans; Infant; Infant, Newborn; Male; Middle Aged; Pharmacovigilance; Tertiary Care Centers; Tramadol; Vancomycin; Young Adult | 2013 |
[Pharmacoeconomic analysis of the treatment of methicillin-resistant Staphylococcus aureus with daptomycin or vancomycin].
Topics: Adult; Aged; Aged, 80 and over; Bacteremia; Computer Simulation; Cost-Benefit Analysis; Daptomycin; Drug Costs; Drug-Related Side Effects and Adverse Reactions; Economics, Pharmaceutical; Endocarditis, Bacterial; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Models, Economic; Monte Carlo Method; Randomized Controlled Trials as Topic; Retrospective Studies; Spain; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2012 |
High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
Topics: Aged; Anti-Bacterial Agents; Cohort Studies; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Prospective Studies; Renal Insufficiency; Safety; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2006 |
Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Drug-Related Side Effects and Adverse Reactions; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitalization; Humans; Infant; Infant, Newborn; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Risk Factors; Vancomycin | 1996 |
Recognizing and reporting adverse drug reactions.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Decision Making; Drug-Related Side Effects and Adverse Reactions; Flushing; Gentamicins; Humans; Hypertension; Male; Mexiletine; Middle Aged; United States; United States Food and Drug Administration; Urticaria; Vancomycin | 1992 |
Using population-based serum drug concentration cutoff values to predict toxicity: test performance and limitations compared with Bayesian interpretation.
Topics: Aminoglycosides; Bayes Theorem; Digoxin; Drug-Related Side Effects and Adverse Reactions; False Negative Reactions; False Positive Reactions; Humans; Pharmacokinetics; Predictive Value of Tests; Probability; Procainamide; Theophylline; Vancomycin | 1990 |